Insiders Beam Therapeutics Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
24.07 ^USD	-1.71%		-0.08%	-11.57%

May. 07	Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates	MT
May. 07	Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Beam Therapeutics Insider Sold Shares Worth $581,617, According to a Recent SEC Filing	Apr. 04	MT
Beam Therapeutics Insider Sold Shares Worth $734,805, According to a Recent SEC Filing	Apr. 04	MT
Beam CEO Andy Bromberg: Bitcoin ETFs a financialisation away from the original essence of crypto	Jan. 30	MT
Beam Therapeutics Inc. Appoints Christi Shaw to Its Board of Directors	Dec. 14	CI
Insider Sell: Beam Therapeutics	23-07-26	MT
Beam Therapeutics Appoints Gopi Shanker as Chief Scientific Officer	23-03-21	MT
Beam Therapeutics Inc. Appoints Gopi Shanker as Chief Scientific Officer	23-03-21	CI
Insider Sell: Beam Therapeutics	23-01-30	MT
Insider Sell: Beam Therapeutics	23-01-25	MT
Insider Sell: Beam Therapeutics	23-01-20	MT
Insider Sell: Beam Therapeutics	23-01-05	MT
Insider Sell: Beam Therapeutics	22-12-15	MT
Beam Therapeutics Named to Boston Globe’s Top Places to Work List for 2022	22-12-02	GL
Beam Therapeutics Named to Boston Globe’s Top Places to Work List for 2022	22-12-02	AQ
Insider Sell: Beam Therapeutics	22-11-02	MT
Beam Therapeutics Inc. Appoints John Lo as Chief Commercial Officer	22-08-09	CI
Insider Sell: Beam Therapeutics	22-07-29	MT
Beam Therapeutics Inc. Announces Executive Changes	22-05-09	CI
Insider Sell: Beam Therapeutics	22-05-03	MT
Beam Therapeutics Appoints John Maraganore, to Its Board of Directors	21-11-08	CI

No results for this search

Beam CEO Andy Bromberg: Bitcoin ETFs a financialisation away from the original essence of crypto

January 30, 2024 at 02:21 pm EST